en.unionpedia.org

Sunovion, the Glossary

On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry and neurology, oncology, urology, women's health, rare disease, and cell and gene therapies.^[1]

29 relations: Amisulpride, Apomorphine, Arformoterol, Bial, Bipolar disorder, Bipolar I disorder, Central nervous system disease, Chronic obstructive pulmonary disease, Cynapsus Therapeutics, Eslicarbazepine acetate, Eszopiclone, Fexofenadine, Focal seizure, Food and Drug Administration, Glycopyrronium bromide, Isomer, Levosalbutamol, Lurasidone, Marion Merrell Dow, Marlborough, Massachusetts, Metabolite, Pharmacology, Respiratory disease, Sanofi, Schizophrenia, Subsidiary, Sumitomo Pharma, Terfenadine, Ulotaront.
Biotechnology companies established in 1984
Pharmaceutical companies established in 1984

Amisulpride

Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses by mouth to treat schizophrenia and acute psychotic episodes.

See Sunovion and Amisulpride

Apomorphine

Apomorphine, sold under the brand name Apokyn among others, is a type of aporphine having activity as a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors.

See Sunovion and Apomorphine

Arformoterol

Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD).

See Sunovion and Arformoterol

Bial

Bial (Portela e C.ª, S.A.) is a pharmaceutical company headquartered in São Mamede do Coronado, in Trofa, Porto district, Portugal.

See Sunovion and Bial

Bipolar disorder

Bipolar disorder, previously known as manic depression, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks.

See Sunovion and Bipolar disorder

Bipolar I disorder

Bipolar I disorder (BD-I; pronounced "type one bipolar disorder") is a type of bipolar spectrum disorder characterized by the occurrence of at least one manic episode, with or without mixed or psychotic features.

See Sunovion and Bipolar I disorder

Central nervous system disease

Central nervous system diseases or central nervous system disorders are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS).

See Sunovion and Central nervous system disease

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation.

See Sunovion and Chronic obstructive pulmonary disease

Cynapsus Therapeutics

Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease.

See Sunovion and Cynapsus Therapeutics

Eslicarbazepine acetate

Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy.

See Sunovion and Eslicarbazepine acetate

Eszopiclone

Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia.

See Sunovion and Eszopiclone

Fexofenadine

Fexofenadine, sold under the brand name Allegra among others, is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever and urticaria.

See Sunovion and Fexofenadine

Focal seizure

Focal seizures (also called partial seizures and localized seizures) are seizures that affect initially only one hemisphere of the brain.

See Sunovion and Focal seizure

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Sunovion and Food and Drug Administration

Glycopyrronium bromide

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group.

See Sunovion and Glycopyrronium bromide

Isomer

In chemistry, isomers are molecules or polyatomic ions with identical molecular formula – that is, the same number of atoms of each element – but distinct arrangements of atoms in space.

See Sunovion and Isomer

Levosalbutamol

Levosalbutamol, also known as levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

See Sunovion and Levosalbutamol